<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04677621</url>
  </required_header>
  <id_info>
    <org_study_id>IRB202002994-N</org_study_id>
    <secondary_id>R01NR014852</secondary_id>
    <nct_id>NCT04677621</nct_id>
  </id_info>
  <brief_title>TEND Study:Telemedicine Nurse DBS for Parkinson's Disease</brief_title>
  <official_title>Telemedicine Nurse DBS for Parkinson's Disease: The TEND Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Nursing Research (NINR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The central hypothesis is that home health nurses can improve access and provide high quality&#xD;
      care when guided by a sophisticated platform that integrates bioinformatics, patient-specific&#xD;
      computational modeling, and continuous symptom measurement.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2022</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of participant clinic visits</measure>
    <time_frame>6 MONTHS from date of enrollment</time_frame>
    <description>The number of in-person clinic visits required for each participant during the 6-month post operative DBS period.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PDQ-39 Scores</measure>
    <time_frame>6-months</time_frame>
    <description>Difference in PDQ-39 scores from baseline to the 6-month time point. PDQ summary index score 0-very good to 100 bad</description>
  </secondary_outcome>
  <other_outcome>
    <measure>UPDRS scores</measure>
    <time_frame>6-months</time_frame>
    <description>Difference in UPDRS scores from baseline to 6-month time point. UPDRS scoring scale 0-very good to 100-bad</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Nurse Telehealth Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Allocated to tele-intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Deep Brain Stimulation (DBS)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Allocated to conventional approach</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nurse Telehealth</intervention_name>
    <description>Subjects will receive nurse telehealth Mobile Decision Support System (MAP) DBS care</description>
    <arm_group_label>Nurse Telehealth Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>STANDARD DBS</intervention_name>
    <description>Subjects will receive standard in-person clinic-based DBS care administered without the use of Mobile Decision Support System (MAP) DBS</description>
    <arm_group_label>Standard Deep Brain Stimulation (DBS)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pre-operative Inclusion Criteria: A good response to levodopa is required in order to&#xD;
             exclude patients with Parkinson's plus syndromes, and will be defined as a 30%&#xD;
             improvement in parkinsonian motor signs based upon the Unified PD Rating Scale (UPDRS)&#xD;
             motor examination subscore, following the administration of 1.5 times the typical&#xD;
             dopaminergic dose during the screening neurological examination. Patients must also&#xD;
             have PD for a minimum of 5 years duration.&#xD;
&#xD;
          -  Additional inclusion criteria consist of: 1) Hoehn &amp; Yahr stage II or worse when off;&#xD;
             2) Intractable, disabling motor fluctuations and/or tremor; 3) Age between 30-75&#xD;
             years; 4) Unsatisfactory clinical response to maximal medical management (with trials&#xD;
             of both higher and lower doses of antiparkinsonian drugs). 5) A stable/optimal medical&#xD;
             regimen of antiparkinsonian drug therapy for at least one month prior to surgery; 6)&#xD;
             access to high-speed internet in the home.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Clinically significant medical disease that would increase the risk of developing pre-&#xD;
             or postoperative complications (e.g. significant cardiac or pulmonary disease,&#xD;
             uncontrolled hypertension).&#xD;
&#xD;
          -  Evidence of secondary or atypical parkinsonism.&#xD;
&#xD;
          -  MRI scan with significant evidence of brain atrophy or other abnormalities.&#xD;
&#xD;
          -  Dementia as evidenced by impairment in two neuropsychological domains and impaired or&#xD;
             borderline neuropsychological function in one additional domain.&#xD;
&#xD;
          -  A major untreated psychiatric disorder.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Okun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adrienne Wright</last_name>
    <phone>352-733-2428</phone>
    <email>adrienne.wright@neurology.ufl.edu</email>
  </overall_contact>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>December 17, 2020</study_first_submitted>
  <study_first_submitted_qc>December 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 21, 2020</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Home Health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

